4//SEC Filing
RespireRx Pharmaceuticals Inc. 4
Accession 0001573202-17-000003
CIK 0000849636operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 7:57 PM ET
Size
11.8 KB
Accession
0001573202-17-000003
Insider Transaction Report
Form 4
MacFarlane Katie
Director
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2017-06-30+25,000→ 25,000 totalExercise: $2.00Exp: 2022-06-30→ common stock (25,000 underlying)
Holdings
- 25,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $3.90Exp: 2022-01-17→ common stock (25,000 underlying) - 30,770
Common Stock Options (to purchase shares of Common Stock)
Exercise: $7.38Exp: 2021-03-31→ common stock (30,770 underlying) - 9.231
Common Stock Options (to purchase shares of Common Stock)
Exercise: $6.40Exp: 2022-08-18→ common stock (9,231 underlying) - 6,154
Common Stock Options (to purchase shares of Common Stock)
Exercise: $8.13Exp: 2022-06-30→ common stock (6,154 underlying)
Footnotes (6)
- [F1]These Common Stock Options vested upon issuance.
- [F2]These Common Stock Options vested in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017, and are all currently vested.
- [F3]The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
- [F4]These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested.
- [F5]These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested.
- [F6]The Common Stock Options vested in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000849636
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 7:57 PM ET
- Size
- 11.8 KB